TRANSIENT SECRETORY IGA DEFICIENCY IN MICE AFTER CYCLOPHOSPHAMIDE TREATMENT

被引:16
作者
COZON, G
CANNELLA, D
PERRIATLANGEVIN, A
JEANNIN, M
TRUBLEREAU, P
ECOCHARD, R
REVILLARD, JP
机构
[1] INSERM U80, CNRS URA 1177 UCBL, Hôpital E. Herriot pavillon P
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1991年 / 61卷 / 01期
关键词
D O I
10.1016/S0090-1229(06)80010-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cyclophosphamide (Cy), an alkylating agent widely used in chemotherapy of leukemia and cancer, causes a well-documented toxicity on hematopoietic and lymphoid cells. Neutropenia is thought to be the main factor involved in infectious complications following antimitotic chemotherapy. Little is known on the effects of these therapies on the mucosal associated lymphoid system which is one of the main barriers against environmental pathogenic agents. The present study examined the effects of a single administration of Cy (200 mg/kg) on murine T and B cell populations of Peyer's patches (PPs), IgA secretion in the proximal part of the small intestine, and plasma cells of the lamina propria. Cy induced in mice a transient decrease in the T and B cell populations of the PPs with a drastic fall of B cell counts and a profound decrease of intestinal IgA secretion due to a reduction of lamina propria plasma cells. This transient secretory IgA deficiency may contribute to the infectious complications following antimitotic chemotherapy. © 1991 Academic Press, Inc.
引用
收藏
页码:93 / 102
页数:10
相关论文
共 25 条
[1]   EFFECT OF RECOMBINANT HUMAN GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR ON CHEMOTHERAPY-INDUCED MYELOSUPPRESSION [J].
ANTMAN, KS ;
GRIFFIN, JD ;
ELIAS, A ;
SOCINSKI, MA ;
RYAN, L ;
CANNISTRA, SA ;
OETTE, D ;
WHITLEY, M ;
FREI, E ;
SCHNIPPER, LE .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (10) :593-598
[2]   AUGMENTATION OF DELAYED-TYPE HYPERSENSITIVITY BY DOSES OF CYCLOPHOSPHAMIDE WHICH DO NOT AFFECT ANTIBODY-RESPONSES [J].
ASKENASE, PW ;
HAYDEN, BJ ;
GERSHON, RK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1975, 141 (03) :697-702
[3]  
BACH JF, 1985, MODE ACTION IMMUNOSU, P175
[4]   IMMUNOBIOLOGY AND IMMUNOPATHOLOGY OF HUMAN GUT MUCOSA - HUMORAL IMMUNITY AND INTRAEPITHELIAL LYMPHOCYTES [J].
BRANDTZAEG, P ;
HALSTENSEN, TS ;
KETT, K ;
KRAJCI, P ;
KVALE, D ;
ROGNUM, TO ;
SCOTT, H ;
SOLLID, LM .
GASTROENTEROLOGY, 1989, 97 (06) :1562-1584
[5]  
BRANDTZAEG P, 1976, SCAND J GASTROEN S36, V11, P1
[6]   PHASE-I/II STUDY OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR IN PATIENTS RECEIVING INTENSIVE CHEMOTHERAPY FOR SMALL CELL LUNG-CANCER [J].
BRONCHUD, MH ;
SCARFFE, JH ;
THATCHER, N ;
CROWTHER, D ;
SOUZA, LM ;
ALTON, NK ;
TESTA, NG ;
DEXTER, TM .
BRITISH JOURNAL OF CANCER, 1987, 56 (06) :809-813
[7]  
CHILDERS NK, 1989, ANNU REV MICROBIOL, V43, P503, DOI 10.1146/annurev.mi.43.100189.002443
[8]  
EBINA T, 1983, LANCET, V2, P1029
[9]   A LAVAGE TECHNIQUE ALLOWING REPEATED MEASUREMENT OF IGA ANTIBODY IN MOUSE INTESTINAL SECRETIONS [J].
ELSON, CO ;
EALDING, W ;
LEFKOWITZ, J .
JOURNAL OF IMMUNOLOGICAL METHODS, 1984, 67 (01) :101-108
[10]   PHASE-I STUDY OF GRANULOCYTE COLONY-STIMULATING FACTOR IN PATIENTS WITH TRANSITIONAL CELL-CARCINOMA OF THE UROTHELIUM [J].
GABRILOVE, JL ;
JAKUBOWSKI, A ;
FAIN, K ;
GROUS, J ;
SCHER, H ;
STERNBERG, C ;
YAGODA, A ;
CLARKSON, B ;
BONILLA, MA ;
OETTGEN, HF ;
ALTON, K ;
BOONE, T ;
ALTROCK, B ;
WELTE, K ;
SOUZA, L .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (04) :1454-1461